Moderna and Merck's mRNA Cancer Vaccine Shows Promise
· Business · Bloomberg, The Independent
Scientists are close to achieving a long-sought milestone using mRNA technology to train the immune system to spot and kill cancer cells. Merck & Co. and Moderna have developed an mRNA cancer vaccine that shows promise in early trials. This breakthrough uses the same mRNA technology as COVID-19 vaccines, marking a significant step in cancer treatment. However, details on the trial results and the specific cancers targeted are not yet provided. Experts suggest this could open new avenues in oncology.
Why it matters
This advancement could revolutionize cancer treatment, offering a new weapon for patients. The mRNA technology's success in vaccines highlights its versatility in medical applications.
Read the original report — Bloomberg
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.